Impairing the emt process appears as a very seductive way to cure breast carcinoma
The sample included patients diagnosed with breast carcinoma
over the period from January 1999 to December 2009.
1) Carcinomas with neuroendocrine features are subclassified into 3 groups: well-differentiated neuroendocrine tumor (WD-NET), which are low-grade tumors that architecturally resemble carcinoid tumors of other sites; poorly differentiated neuroendocrine carcinoma (PD-NEC) or small cell carcinoma, which is identical to its pulmonary counterpart; and invasive breast carcinoma
with neuroendocrine differentiation (IBC-NED), which is a breast carcinoma
of special or no special type that demonstrates neuroendocrine differentiation by immunohistochemistry.
Subsequent staining for breast carcinoma
marker mammaglobin was negative and evidence of ductal carcinoma in situ was absent.
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
is a malignant disease with a variable prognosis.
Methods: This retrospective study was conducted at Jordan University Hospital, Amman, Jordan, and comprised cases of breast carcinoma
among females between 2006 and 2015.
According to the company, Doxophos has been approved for use in the treatment of acute lymphoblastic leukaemia, acute myeloblastic leukaemia, chronic leukaemia, Hodgkin's disease and non-Hodgkin's lymphoma, multiple myeloma, osteogenic sarcoma, Ewing's sarcoma, soft tissue sarcoma, neuroblastoma, rhabdomyosarcoma, Wilms' tumour, breast carcinoma
, endometrial cancer, ovarian carcinoma, germ cell tumours, prostatic carcinoma, lung cancer, gastric carcinoma, head and neck cancer and thyroid carcinoma.
A painless lump beneath the areola, usually discovered by the patient himself is the most common presenting symptoms in the male breast carcinoma
These rare breast lesions are fibromatosis, idiopathic granulomatous mastitis, tubular adenoma, diabetic mastopathy, invasive micropapillary carcinoma, osteoclastic giant cell breast carcinoma
, malignant phyllodes tumor, carcinoma arising in fibroadenoma, metastasis, and metaplastic carcinoma.
Key words: Argyrophilic Nucleolar Organizer Regions, Breast carcinoma
, Bloom and Richardson Grade, Estrogen receptor.
Technical aspects of testing procedures for GEA and breast carcinoma
are identical, but there are important differences in interpretation of IHC results between the two tumor types.